Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qihuang Zhengqi
- Development stage
- Unknown
- Lead developer
- Jiangsu Kanion Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Qihuang Zhengqi (also known as Qihuang Zhengqi Granules) is an innovative Traditional Chinese Medicine (TCM) Class 1.1 drug developed by Jiangsu Kanion Pharmaceutical in collaboration with Shanghai Tufeng Pharmaceutical Technology and Shanghai University of Traditional Chinese Medicine. Formulated under the guidance of traditional Chinese medicine theory, it is designed to benefit qi, nourish blood, and support vital qi (fu zheng bu xu). Qihuang Zhengqi is primarily being developed for the treatment of cancer-related fatigue (CRF) with qi and blood deficiency syndrome. In preclinical studies, it demonstrated significant therapeutic effects by enhancing physical endurance, inhibiting lactic acid accumulation and glycogen depletion, and improving survival in tumor cachexia and chemotherapy-induced fatigue models. In July 2026, the National Medical Products Administration (NMPA) of China approved the initiation of clinical trials for Qihuang Zhengqi Granules.
- Brand names
- Qihuang Zhengqi Granules
- Other names
- 芪黄正气芪黄正气颗粒
Beyond the preview
Go deeper on Qihuang Zhengqi.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qihuang Zhengqi.